SNCA and Parkinson disease: In this study, we employed a previously used differentiation protocol to generate human-like dopamine neurons from a PD patient with α-synuclein triplication (AST) and an unaffected first-degree relative (NAS), serving as a control with a similar genetic background to minimize phenotypic differences.